Fred Hutchinson Cancer Research Center, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center's four scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center, in collaboration with its clinical and research partners, the University of Washington and Children's Hospital and Regional Medical Center, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Join us and make a difference.
A Postdoctoral Research Fellow position is available immediately in the Clinical Research Division of the Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA. The successful applicant will work with Dr. Matthias Stephan (https://stephanlab-fhcrc.squarespace.com) to explore the fast-developing and highly interdisciplinary field of immunobioengineering for adoptive T-cell therapy. Using next-generation immunomodulatory synthetic materials, the postdoctoral fellow will develop new approaches – beyond existing T-cell-based therapies – to therapeutically manipulate the immune system against cancer.
The successful applicant will fabricate stimulatory biomaterial devices, drug delivery systems and bioactive substances and test their therapeutic potential in preclinical tumor models of adoptive T-cell therapy. The FHCRC provides a highly interactive and supportive environment for junior investigators to grow and develop their future career; it consistently ranks in the top 20 best places to work for postdocs, as surveyed by The Scientist.
Suitable applicants should have a PhD degree in immunology or bioengineering.
The candidate must have a strong knowledge of primary immune cell isolation and culture, flow cytometry, and advanced training in animal procedures such as tail vein injections and the establishment of advanced in vivo murine tumor models. The position further requires a basic understanding of genetic engineering and protein expression. The successful candidate will be a scientifically driven, well organized self-starter.
We are a VEVRAA Federal Contractor.